Cargando…

Alteration of Metabolic Profiles during the Progression of Alzheimer’s Disease

(1) Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that threatens the population health of older adults. However, the mechanisms of the altered metabolism involved in AD pathology are poorly understood. The aim of the study was to identify the potential biomarkers o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Wuhan, Chen, Lihua, Li, Xuebing, Han, Tingli, Yang, Yang, Hu, Cheng, Yu, Weihua, Lü, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605479/ https://www.ncbi.nlm.nih.gov/pubmed/37891827 http://dx.doi.org/10.3390/brainsci13101459

Ejemplares similares

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis
por: Yu, Wuhan, et al.
Publicado: (2021)

Alteration of Metabolic Profile and Potential Biomarkers in the Plasma of Alzheimer’s Disease
por: Shao, Yaping, et al.
Publicado: (2020)

Alteration of the microRNA network during the progression of Alzheimer's disease
por: Lau, Pierre, et al.
Publicado: (2013)

The psychological impact on patients with memory disorders and their caregivers during COVID-19
por: Yuan, Shiyun, et al.
Publicado: (2021)

Single-nucleus transcriptional profiling uncovers the reprogrammed metabolism of astrocytes in Alzheimer’s disease
por: Fan, Li-Yuan, et al.
Publicado: (2023)

Identification of metabolism-related subtypes and feature genes in Alzheimer’s disease
por: Lian, Piaopiao, et al.
Publicado: (2023)

The Cardiac Dysfunction Caused by Metabolic Alterations in Alzheimer's Disease
por: Murphy, Jiayuan, et al.
Publicado: (2022)

Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
por: Yan, Xu, et al.
Publicado: (2020)

Brain Metabolic Alterations in Alzheimer’s Disease
por: Ardanaz, Carlos G., et al.
Publicado: (2022)

Alzheimer’s disease progression characterized by alterations in the molecular profiles and biogenesis of brain extracellular vesicles
por: Gallart-Palau, Xavier, et al.
Publicado: (2020)

Functional alterations of myeloid cells during the course of Alzheimer’s disease
por: Thome, Aaron D., et al.
Publicado: (2018)

Sex differences in the progression of glucose metabolism dysfunction in Alzheimer’s disease
por: Park, Jong-Chan, et al.
Publicado: (2023)

Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression
por: Chang, Ming-Ling, et al.
Publicado: (2020)

Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer’s disease
por: Moreno-Rodriguez, Marta, et al.
Publicado: (2020)

Altered global signal topography in Alzheimer's disease
por: Chen, Pindong, et al.
Publicado: (2023)

Alterations in metabolic pathways and networks in Alzheimer's disease
por: Kaddurah-Daouk, R, et al.
Publicado: (2013)

Metabolic profiling of Alzheimer's disease brains
por: Inoue, Koichi, et al.
Publicado: (2013)

Unraveling the Possibilities: Recent Progress in DNA Biosensing
por: Yu, Meng, et al.
Publicado: (2023)

Gait Indicators Contribute to Screening Cognitive Impairment: A Single- and Dual-Task Gait Study
por: Wang, Xiaoqin, et al.
Publicado: (2023)

Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression
por: Findley, Caleigh A., et al.
Publicado: (2019)

Altered DNA methylome profiles of blood leukocytes in Chinese patients with mild cognitive impairment and Alzheimer’s disease
por: Wu, Shaochang, et al.
Publicado: (2023)

Altered Gut Microbial Profile Accompanied by Abnormal Fatty Acid Metabolism Activity Exacerbates Endometrial Cancer Progression
por: Zhao, Shan-Shan, et al.
Publicado: (2022)

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023)

Alterations in Glycerolipid and Fatty Acid Metabolic Pathways in Alzheimer's Disease Identified by Urinary Metabolic Profiling: A Pilot Study
por: Watanabe, Yumi, et al.
Publicado: (2021)

Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
por: Chen, Hsu-Hsin, et al.
Publicado: (2018)

Plasmon-activated water as a therapeutic strategy in Alzheimer’s disease by altering gut microbiota
por: Cheng, Chia-Hsiung, et al.
Publicado: (2023)

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
por: Gui, YaXing, et al.
Publicado: (2015)

The N‐glycan profile in cortex and hippocampus is altered in Alzheimer disease
por: Gaunitz, Stefan, et al.
Publicado: (2020)

Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease
por: Yu, Chiun-Chieh, et al.
Publicado: (2016)

Systemic and central nervous system metabolic alterations in Alzheimer’s disease
por: van der Velpen, Vera, et al.
Publicado: (2019)

Degenerative alterations in noradrenergic neurons of the locus coeruleus in Alzheimer's disease
por: Liu, Lihua, et al.
Publicado: (2013)

Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma
por: Cai, Fei-Fei, et al.
Publicado: (2020)

Alteration of immunoproteome profile of Echinococcus granulosus hydatid fluid with progression of cystic echinococcosis
por: Ahn, Chun-Seob, et al.
Publicado: (2015)

Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
por: Shen, Xue‐Ning, et al.
Publicado: (2020)

Human Brain and Blood N-Glycome Profiling in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias
por: Yu, Lei, et al.
Publicado: (2021)

Metabolic profiling distinguishes three subtypes of Alzheimer's disease
por: Bredesen, Dale E.
Publicado: (2015)

Metabolic Alterations in Pancreatic Cancer Progression
por: Vernucci, Enza, et al.
Publicado: (2019)

Heterogeneity of Alzheimer’s disease identified by neuropsychological test profiling
por: Nguyen, Truc Tran Thanh, et al.
Publicado: (2023)

Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis
por: Yang, Fan, et al.
Publicado: (2021)

Alzheimer’s disease alters the transcriptomic profile of natural killer cells at single-cell resolution
por: Qi, Caiyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eu3aip0pojdq9j94fscb291k4s